Table 2.

Factors predicting respiratory hospitalization in patients with bronchiectasis.

	Univariate analysis			Multivariate analysis
	OR	95% CI	p-value	OR	95% CI	p-value
Albumin
≥3.5 g/dL	1			1
<3.5 g/dL	9.625	2.891–32.05	<0.001	5.814	1.209–27.955	0.028
C-reactive protein, (mg/L)	1.061	1.026–1.097	<0.001	1.053	1.010–1.099	0.016
Body mass index (kg/m2)	0.843	0.755–0.941	0.002	0.921	0.802–1.058	0.245
FEV1 (% predicted)	0.963	0.946–0.980	<0.001	0.992	0.967–1.017	0.522
mMRC dyspnea score	2.549	1.513–4.292	<0.001	2.583	1.208–5.527	0.014
Number of exacerbations in the previous year	2.082	1.392–3.113	<0.001	1.474	0.898–2.420	0.125
Chronic colonization with Pseudomonas aeruginosa	5.476	2.563–11.696	<0.001	3.466	1.334–9.006	0.011
Chronic colonization with other organisms	2.941	1.380–6.267	0.005	3.428	1.187–9.896	0.023
Number of affected lobes	1.547	1.210–1.977	0.001	1.247	0.868–1.790	0.232
Cystic bronchiectasis patterna	2.731	1.378–5.413	0.004	1.135	0.433–2.976	0.796

CI, confidence interval; FEV₁, forced expiratory volume in 1 second; mMRC, modified Medical Research Council; OR, odds ratio.

^a Compared with both cylindrical and varicose patterns.